Atropine Sulfate Market Analysis

The atropine sulfate market is segmented by product, by application, by distribution channel and by region. Based on product, the market is segmented into injection and ointment, out of which, the segment for injections is anticipated to dominate the market owing to the properties such as ease of administration since the drug is directly injected into veins and it starts working within a minute and the effect lasts for about an hour. Based on distribution channel, the market is further divided into hospital pharmacies, retail pharmacies and online pharmacies. Out of these, the segment for hospital pharmacy is estimated to hold the largest market share owing to the large number of ophthalmic surgeries taking place around the world.

Our in-depth analysis of the global market includes the following segments:

By Product Type	Injection Ointment
By Application Type	Ophthalmology Gastrointestinal Neurology Other
By Distribution Channel Type	Hospital Pharmacy Retail Pharmacy Online Pharmacy

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of atropine sulfate is evaluated at USD 105.25 million.

Atropine Sulfate Market size was over USD 101.36 million in 2023 and is poised to exceed USD 186.45 million by 2036, witnessing over 4.8% CAGR during the forecast period i.e., between 2024-2036.

North America industry is poised to account for largest revenue share by 2036, propelled by presence of some of the key players that are also traditional suppliers of medicinal drugs.

The major players in the market are Meridian Medical Technologies, Inc., Novartis AG, Teligent, CÂ²PHARMA, RESONANCE LABORATORIES, China Resources Double-crane Pharmaceutical Co., Ltd., Albany Molecular Research Inc., Alchem International Pvt. Ltd., Saurav Chemicals Ltd., Wuhan senwayer century chemical Co., Ltd., and others.

Atropine Sulfate Market Analysis